Clinical Trial Update: LY353381 in Preventing Breast Cancer in Women With Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 trial of LY353381 to prevent breast cancer in women with breast hyperplasia completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LY353381

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30